Canopy Growth (CGC) Expected to Announce Earnings on Friday

Key Points

• Canopy Growth is expected to report Q2 2027 results before market open on Friday, November 6, 2026. Analysts forecast a loss of $0.03 per share and revenue of $57.72 million; the earnings call is scheduled for 10:00 a.m. ET.
• In its prior quarter, Canopy Growth reported a $0.02-per-share loss, beating estimates for a $0.04 loss, while revenue of $142.62 million exceeded the $58.21 million consensus estimate.
• The stock opened at $0.68, near its 52-week low of $0.65, and analysts maintain a consensus “Hold” rating. Two firms recently downgraded the shares to “Sell.”

Canopy Growth (NASDAQ:CGC - Get Free Report) is anticipated to release its Q2 2027 results before the market opens on Friday, November 6th. Analysts expect the company to announce earnings of ($0.03) per share and revenue of $57.72 million for the quarter. Parties can find conference call details on the company's upcoming Q2 2027 earnings results page for the latest details on the call scheduled for Friday, November 6, 2026 at 10:00 AM ET.

Canopy Growth (NASDAQ:CGC - Get Free Report) last posted its earnings results on Friday, August 7th. The company reported ($0.02) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.04) by $0.02. The business had revenue of $142.62 million during the quarter, compared to analyst estimates of $58.21 million. Canopy Growth had a negative return on equity of 21.91% and a negative net margin of 65.33%. On average, analysts expect Canopy Growth to post ($0.10) EPS for the current fiscal year and ($0.07) EPS for the next fiscal year.

Canopy Growth Stock Up 0.5%

Shares of NASDAQ:CGC opened at $0.68 on Friday. The company has a quick ratio of 2.39, a current ratio of 3.04 and a debt-to-equity ratio of 0.31. Canopy Growth has a 52-week low of $0.65 and a 52-week high of $2.38. The company has a 50 day moving average of $0.88 and a two-hundred day moving average of $1.00. The company has a market capitalization of $303.28 million, a price-to-earnings ratio of -1.50 and a beta of 0.78.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on CGC shares. Weiss Ratings lowered shares of Canopy Growth from a "sell (d-)" rating to a "sell (e+)" rating in a report on Friday, October 16th. Wall Street Zen downgraded shares of Canopy Growth from a "hold" rating to a "sell" rating in a research note on Saturday, October 17th. Two research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold".

Canopy Growth Company Profile

Canopy Growth Corporation is a cannabis company headquartered in Smiths Falls, Ontario, Canada. Founded in 2013, the company operates in the production, distribution and sale of cannabis and cannabis-related products for adult-use and medical markets.

Its product portfolio includes dried cannabis flower, pre-rolls, cannabis oils, softgels, vapes, beverages and edibles. Canopy Growth markets products under several brands, including Tweed, 7ACRES, Doja and Deep Space, with offerings designed for different consumer preferences and product segments.

Canopy Growth primarily serves the Canadian recreational and medical cannabis markets and has pursued international opportunities in selected medical-cannabis markets.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.